Endo presses pause on litigation after FDA assurance to sort out compounding competition by year-end

Endo presses pause on litigation after FDA assurance to sort out compounding competition by year-end

Source: 
Fierce Pharma
snippet: 
Endo Pharmaceuticals’ on-again, off-again lawsuit, aimed at keeping the FDA from giving bulk compounders the ability to compete with one of it key drugs, is off again.